| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,225,000 | 3,115,000 | 2,783,000 | 3,188,000 | | Cost of Revenue | 1,989,000 | 1,898,000 | 1,718,000 | 2,029,000 | | | Gross Profit | 1,236,000 | 1,217,000 | 1,065,000 | 1,159,000 | | | Operating Expenses | | Research Development | 95,000 | 97,000 | 94,000 | 107,000 | | Selling General and Administrative | 732,000 | 721,000 | 726,000 | 711,000 | | Non Recurring | 3,000 | 3,000 | 190,000 | 138,000 | | Others | 120,000 | 119,000 | 118,000 | 118,000 | | | | Total Operating Expenses | 950,000 | 940,000 | 1,128,000 | 1,074,000 | | | | Operating Income or Loss | 286,000 | 277,000 | (63,000) | 85,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 36,000 | 25,000 |
-
| 101,000 | | Earnings Before Interest And Taxes | 322,000 | 302,000 | (63,000) | 189,000 | | Interest Expense | 47,000 | 49,000 | 48,000 | 61,000 | | Income Before Tax | 275,000 | 253,000 | (111,000) | 128,000 | | Income Tax Expense | 90,000 | 84,000 | (20,000) | 46,000 | | Minority Interest | 43,000 | (43,000) |
-
| (11,000) | | | | Net Income From Continuing Ops | 228,000 | 126,000 | (91,000) | 71,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 228,000 | 126,000 | (91,000) | 71,000 | | Preferred Stock And Other Adjustments | (69,000) | 20,000 | (20,000) |
-
| | | Net Income Applicable To Common Shares | $159,000 | $146,000 | ($111,000) | $71,000 |
|
0.22% Nasdaq 
Income Statement
